Switch or Sequential Combination Therapy of Peginterferon in Hepatitis B Patients With Longterm Entecavir Therapy
Status:
Unknown status
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, prospective cohort study to evaluate the efficacy and safety of
sequential combination or switch therapy of pegylated interferon alfa-2a in chronic hepatitis
B patients with low HBsAg and HBeAg titers after long-term entecavir therapy, and compared to
those who continued on ETV therapy.